NCT00225420 Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00223665 Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer Status COMPLETED Phase PHASE2
NCT00223171 Duration of Androgen Blockade Combined With Pelvic Irradiation in Prostate Cancers Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT00223145 Study on the Role of Hormonal Treatment for Two Dosage Levels of Prostate Radiation Therapy Versus Prostate Radiation Therapy Alone Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT00219271 Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer Status COMPLETED Phase PHASE4
NCT00219219 Zoledronic Acid in the Prevention of Skeletal-related Events in Hormone Refractory and Hormone-sensitive Prostate Cancer Patients With Bone Metastases Status COMPLETED Phase PHASE4
NCT00218205 A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer Status UNKNOWN Phase PHASE2
NCT00217516 Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer Status COMPLETED Phase PHASE1
NCT00217464 Fulvestrant in Treating Patients With Recurrent Prostate Cancer Status TERMINATED Phase PHASE2
NCT00216099 Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate Cancer Status COMPLETED Phase PHASE2
NCT00215709 Bi-Weekly Administration of Docetaxel for Older Men With Hormone Refractory Prostate Cancer Status COMPLETED Phase PHASE1
NCT00215683 An Extension Study Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Depots in Prostate Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT00215657 Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients Status TERMINATED Phase PHASE2
NCT00215631 Can Tadalafil Maintain Erectile Function In Patients Treated With Radiotherapy For Prostate Cancer? Status TERMINATED Phase PHASE3
NCT00215345 A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer Status UNKNOWN Phase PHASE2
NCT00214422 Intensity Modulated Radiation Therapy for Prostate Cancer Status COMPLETED Phase EARLY_PHASE1
NCT00214162 CHESS Caregivers Study: Web-based Support for Informal Caregivers in Cancer Status COMPLETED Phase NA
NCT00214136 Intensity Modulated Radiation Therapy (IMRT) Radiotherapy for Treating Prostate Pelvic Nodes Status COMPLETED Phase PHASE2
NCT00214097 Phase I/II Hypofractionated Radiotherapy for Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00208988 A Randomized Controlled Trial to Promote Physician-Patient Discussion of Prostate Cancer Screening Status COMPLETED Phase NA